Forte Biosciences, Inc. (FBRX)
USD 18.75
(-4.63%)
USD 18.75
(-4.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.7 Million | -8.18 Million | -16.67 Million | -18.42 Million | -2.77 Million | -34.46 Million |
| Net Income | -31.47 Million | -13.87 Million | -21.7 Million | -46.48 Million | -4.06 Million | -48.95 Million |
| Depreciation & Amortization | 9000.00 | - | 36 Thousand | 54 Thousand | 10.99 Thousand | 625 Thousand |
| Deferred income taxes | -271 Thousand | - | - | - | 918 Thousand | -6.87 Million |
| Stock-based compensation | 3.28 Million | 4.01 Million | 4.21 Million | 956 Thousand | 35.71 Thousand | 6.87 Million |
| Change in working capital | -392 Thousand | 1.67 Million | 720 Thousand | -3.83 Million | 1.25 Million | 6.07 Million |
| Other non-cash items | 140 Thousand | 3.8 Million | 61 Thousand | 30.88 Million | -918 Thousand | 7.77 Million |
| Investing Cash Flow | 47 Thousand | - | - | 3.58 Million | -161.59 Thousand | -4.19 Million |
| Investments in PPE | -88 Thousand | - | - | - | -161.59 Thousand | -1.96 Million |
| Acquisitions | -135.00 | - | - | 3582.00 | - | 2.22 Million |
| Investment purchases | -9.96 Million | - | - | - | - | -70.74 Million |
| Sales/Maturities of investments | 10.1 Million | - | - | - | - | 68.52 Million |
| Other Investing Activities | 135.00 | - | - | 3.57 Million | 42.31 Million | -2.22 Million |
| Financing Cash Flow | 24.68 Million | 7.24 Million | -44 Thousand | 66.66 Million | 4.85 Million | 43.53 Million |
| Debt repayment | - | - | - | - | - | -23.32 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -60.00 | - | - | - | - | 28.86 Million |
| Common Stock Issuance | 24.74 Million | 7.22 Million | 62 Thousand | 66.69 Million | 4.85 Million | 28.84 Million |
| Other Financing Activities | -60 Thousand | 12 Thousand | -106 Thousand | -32 Thousand | 4.85 Million | -8.63 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 271 Thousand | 207 Thousand | -294 Thousand | -369 Thousand | 976.1 Thousand | 1.26 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -663 Thousand | 1.47 Million | 1.01 Million | -3.46 Million | 274.83 Thousand | 4.81 Million |
| Cash at beginning of period | 41.1 Million | 42.04 Million | 58.76 Million | 6.93 Million | 5.01 Million | 35.93 Million |
| Cash at end of period | 11.96 Million | 41.1 Million | 42.04 Million | 58.76 Million | 6.93 Million | 40.81 Million |
| Capital Expenditure | -88 Thousand | - | - | - | -161.59 Thousand | -1.96 Million |
| Effect of forex changes on cash | -25.16 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -29.13 Million | -944 Thousand | -16.72 Million | 51.82 Million | 1.92 Million | 4.88 Million |
| Free Cash Flow | -28.79 Million | -8.18 Million | -16.67 Million | -18.42 Million | -2.93 Million | -36.43 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.51 Million | -7.42 Million | -31.47 Million | -5.87 Million | -9.95 Million | -8.89 Million |
| Depreciation & Amortization | 10 Thousand | 9000.00 | 9000.00 | 6000.00 | 3000.00 | - |
| Deferred income taxes | - | - | -271 Thousand | -4.65 Million | -3000.00 | - |
| Stock-based compensation | 802 Thousand | 805 Thousand | 3.28 Million | 780 Thousand | 772 Thousand | 855 Thousand |
| Change in working capital | 5.76 Million | -55 Thousand | -392 Thousand | -3.89 Million | 240 Thousand | 2.58 Million |
| Other non-cash items | -2.77 Million | 556 Thousand | 140 Thousand | 4.66 Million | -115 Thousand | -21 Thousand |
| Investing Cash Flow | - | -6000.00 | 47 Thousand | -16 Thousand | 10.02 Million | -9.96 Million |
| Investments in PPE | - | -6000.00 | -88 Thousand | -17 Thousand | -71 Thousand | - |
| Acquisitions | - | - | -135.00 | - | - | - |
| Investment purchases | - | - | -9.96 Million | - | - | -9.96 Million |
| Sales/Maturities of investments | - | - | 10.1 Million | 1000.00 | 10.09 Million | - |
| Other Investing Activities | - | - | 135.00 | 1.00 | 10.09 Thousand | -9965.00 |
| Financing Cash Flow | -10 Thousand | -8000.00 | 24.68 Million | -75 Thousand | 24.77 Million | -24 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -10 Thousand | -16 Thousand | -60.00 | -75.00 | -24.00 | -24.00 |
| Common Stock Issuance | - | 8000.00 | 24.74 Million | -63 Thousand | 24.82 Million | -24 Thousand |
| Other Financing Activities | -10 Thousand | -16 Thousand | -60 Thousand | -12 Thousand | -48 Thousand | 24.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.59 Million | 261 Thousand | 271 Thousand | -3.86 Million | 2.28 Million | 1.66 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.17 Million | -316 Thousand | -663 Thousand | -25 Thousand | -2.04 Million | 923 Thousand |
| Cash at beginning of period | 10.63 Million | 11.96 Million | 41.1 Million | 21.14 Million | 20.43 Million | 35.9 Million |
| Cash at end of period | 9.57 Million | 10.63 Million | 11.96 Million | 11.96 Million | 46.18 Million | 20.43 Million |
| Capital Expenditure | - | -6000.00 | -88 Thousand | -17 Thousand | -71 Thousand | - |
| Effect of forex changes on cash | - | - | -25.16 Million | -123 Thousand | - | - |
| Net cash flow / Change in cash | -1.05 Million | -1.32 Million | -29.13 Million | -9.18 Million | 25.74 Million | -15.46 Million |
| Free Cash Flow | -5.93 Million | -6.67 Million | -28.79 Million | -8.98 Million | -9.12 Million | -5.47 Million |
MKG
MARK
HBT
CPL
000025
WLRMF